Trade Mark Journal No.2025/039 26 September 2025
WO0000001875468 (5,42)
Office of origin: United States of America
Date of International Registration:7 August 2025
Date of designation in the UK:
7 August 2025

The mark consists of a stylized eight-point star design followed by "ARCHONBIO", with "ARCHON" in bold font.
International priority date claimed: 7 February 2025
(United States of America)
(99033219)
- Class 5
- Biological preparations for pharmaceutical purposes; biological preparations for preventing, diagnosing, treating and managing cancer, tumors, and respiratory diseases; biological preparations for use in oncology, immunology, and pulmonology; biological preparations, namely, custom engineered protein-antibody compounds for medical purposes; biologic compounds being a component of biological preparations for cancer, tumors, and respiratory diseases; therapeutic agents for enhancing drug delivery, biodistribution, and cell target engagement.
- Class 42
- Research in the fields of biotechnology, biologics, proteins, protein therapeutics, protein design, and antibodies; design, engineering, and development of biologics, proteins, protein therapeutics, protein design, and antibodies; laboratory services for biomanufacturing; drug discovery services.
Archon Biosciences, Inc.
Representative: Karen Won Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C, One Financial Center, Boston MA 02111, UNITED STATES OF AMERICA